Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma
Status:
Completed
Trial end date:
2017-12-29
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to characterize the bronchodilator effects and safety of 25 ug
and 50 ug o.d. NVA237 (glycopyrronium bromide) doses compared to placebo in asthma patients